Neurotoxizität bei Zytostatikatherapie: eine Ubersicht.

Translated title of the contribution: Neurotoxicity with cytostatic therapy: a review

T. Cerny, C. Meier

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Neurotoxicity is of increasing importance in the treatment of cancer patients. Since the dose-limiting hematological toxicity of most cytostatic drugs can now be overcome by modern supportive therapy, high-dose chemotherapy with curative intent can be used more often. Non-hematological toxicities such as neurotoxicity will therefore become dose-limiting with greater frequency, and to avoid disabling neurological side effects of chemotherapy the drug-induced neurological disturbances must be recognized before irreversible damage has occurred. The neurological side effects of the cytostatic drugs are reviewed.

Original languageGerman
Pages (from-to)1137-1147
Number of pages11
JournalSchweizerische Medizinische Wochenschrift
Volume119
Issue number34
StatePublished - Aug 26 1989
Externally publishedYes

Fingerprint

Cytostatic Agents
Drug-Related Side Effects and Adverse Reactions
Drug Therapy
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Neurotoxizität bei Zytostatikatherapie : eine Ubersicht. / Cerny, T.; Meier, C.

In: Schweizerische Medizinische Wochenschrift, Vol. 119, No. 34, 26.08.1989, p. 1137-1147.

Research output: Contribution to journalArticle

Cerny, T. ; Meier, C. / Neurotoxizität bei Zytostatikatherapie : eine Ubersicht. In: Schweizerische Medizinische Wochenschrift. 1989 ; Vol. 119, No. 34. pp. 1137-1147.
@article{3689f27873c94c7fac2dbf49473d80cb,
title = "Neurotoxizit{\"a}t bei Zytostatikatherapie: eine Ubersicht.",
abstract = "Neurotoxicity is of increasing importance in the treatment of cancer patients. Since the dose-limiting hematological toxicity of most cytostatic drugs can now be overcome by modern supportive therapy, high-dose chemotherapy with curative intent can be used more often. Non-hematological toxicities such as neurotoxicity will therefore become dose-limiting with greater frequency, and to avoid disabling neurological side effects of chemotherapy the drug-induced neurological disturbances must be recognized before irreversible damage has occurred. The neurological side effects of the cytostatic drugs are reviewed.",
author = "T. Cerny and C. Meier",
year = "1989",
month = "8",
day = "26",
language = "German",
volume = "119",
pages = "1137--1147",
journal = "Schweizerische Medizinische Wochenschrift",
issn = "0036-7672",
publisher = "EMH Swiss Medical Publishers Ltd.",
number = "34",

}

TY - JOUR

T1 - Neurotoxizität bei Zytostatikatherapie

T2 - eine Ubersicht.

AU - Cerny, T.

AU - Meier, C.

PY - 1989/8/26

Y1 - 1989/8/26

N2 - Neurotoxicity is of increasing importance in the treatment of cancer patients. Since the dose-limiting hematological toxicity of most cytostatic drugs can now be overcome by modern supportive therapy, high-dose chemotherapy with curative intent can be used more often. Non-hematological toxicities such as neurotoxicity will therefore become dose-limiting with greater frequency, and to avoid disabling neurological side effects of chemotherapy the drug-induced neurological disturbances must be recognized before irreversible damage has occurred. The neurological side effects of the cytostatic drugs are reviewed.

AB - Neurotoxicity is of increasing importance in the treatment of cancer patients. Since the dose-limiting hematological toxicity of most cytostatic drugs can now be overcome by modern supportive therapy, high-dose chemotherapy with curative intent can be used more often. Non-hematological toxicities such as neurotoxicity will therefore become dose-limiting with greater frequency, and to avoid disabling neurological side effects of chemotherapy the drug-induced neurological disturbances must be recognized before irreversible damage has occurred. The neurological side effects of the cytostatic drugs are reviewed.

UR - http://www.scopus.com/inward/record.url?scp=0024409984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024409984&partnerID=8YFLogxK

M3 - Article

C2 - 2554491

AN - SCOPUS:0024409984

VL - 119

SP - 1137

EP - 1147

JO - Schweizerische Medizinische Wochenschrift

JF - Schweizerische Medizinische Wochenschrift

SN - 0036-7672

IS - 34

ER -